Identification of promising anti-EBOV inhibitors: de novo drug design, molecular docking and molecular dynamics studies

por Mohamed, Eslam A. R., Abdelwahab, Sayed F., Alqaisi, Ahmad M., Nasr, Amaal Mohammed Salih, Hassan, Heba Ali
Publicado 2022

A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease

por Elkaeed, Eslam B., Eissa, Ibrahim H., Elkady, Hazem, Abdelalim, Ahmed, Alqaisi, Ahmad M., Alsfouk, Aisha A., Elwan, Alaa, Metwaly, Ahmed M.
Publicado 2022

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing

por Mohamed, Eslam A. R., Abdel-Rahman, Islam M., Zaki, Magdi E. A., Al-Khdhairawi, Ahmad, Abdelhamid, Mahmoud M., Alqaisi, Ahmad M., Rahim, Lyana binti Abd, Abu-Hussein, Bilal, El-Sheikh, Azza A. K., Abdelwahab, Sayed F., Hassan, Heba Ali
Publicado 2023